000 | 01922 a2200469 4500 | ||
---|---|---|---|
005 | 20250516203832.0 | ||
264 | 0 | _c20141124 | |
008 | 201411s 0 0 eng d | ||
022 | _a1815-7920 | ||
024 | 7 |
_a10.5588/ijtld.13.0457 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNapiórkowska, A | |
245 | 0 | 0 |
_aCharacterisation of pyrazinamide-resistant Mycobacterium tuberculosis strains isolated in Poland and Germany. _h[electronic resource] |
260 |
_bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _cApr 2014 |
||
300 |
_a454-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAmidohydrolases _xgenetics |
650 | 0 | 4 |
_aAntitubercular Agents _xtherapeutic use |
650 | 0 | 4 | _aBacteriological Techniques |
650 | 0 | 4 | _aDNA Mutational Analysis |
650 | 0 | 4 |
_aDNA, Bacterial _xgenetics |
650 | 0 | 4 |
_aDrug Resistance, Bacterial _xgenetics |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aGermany |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aMinisatellite Repeats |
650 | 0 | 4 | _aMolecular Epidemiology |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aPoland |
650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
650 | 0 | 4 |
_aPyrazinamide _xtherapeutic use |
650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdiagnosis |
700 | 1 | _aRüsch-Gerdes, S | |
700 | 1 | _aHillemann, D | |
700 | 1 | _aRichter, E | |
700 | 1 | _aAugustynowicz-Kopeć, E | |
773 | 0 |
_tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _gvol. 18 _gno. 4 _gp. 454-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.5588/ijtld.13.0457 _zAvailable from publisher's website |
999 |
_c23678480 _d23678480 |